课题基金 / 基金详情

MULTICENTER 34 WEEK STUDY OF INVINAVIR/NELFINAVIR IN HIV 1 SEROPOSITIVE PATIENTS

MULTICENTER 34 WEEK STUDY OF INVINAVIR/NELFINAVIR IN HIV 1 SEROPOSITIVE PATIENTS
Invinavir/Nelfinavir 在 HIV 1 血清阳性患者中的多中心 34 周研究
批准号：
6275850
负责人：
SHARON RIDDLER
金额：
$1.91万
依托单位：
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6275850
关键词：
AIDS therapy HIV infections antiAIDS agent antiviral agents clinical research clinical trials combination chemotherapy drug screening /evaluation human immunodeficiency virus 1 human subject human therapy evaluation pharmacokinetics protease inhibitor

项目摘要

项目成果

SHARON RIDDLER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a parallel time lagged 2 panel multiple dose 24 week study designed to evaluate the safety and tolerability of the coadministration of indinavir 1000 mg q12h and nelfinavir 750 mg q12h. Additionally, pharmacokinetics of both as well as the antiretroviral activity of the combination will be evaluated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Native-like Envelope Trimer Therapeutic Vaccination for Induction of Broadly Neutralizing Antibodies to Facilitate HIV Functional Cure
Native-like Envelope Trimer Therapeutic Vaccination for Induction of Broadly Neutralizing Antibodies to Facilitate HIV Functional Cure
Native-like Envelope Trimer Therapeutic Vaccination for Induction of Broadly Neutralizing Antibodies to Facilitate HIV Functional Cure
AN ASSESSMENT OF ORAL MUCOSAL IMMUNITY IN HIV-1 INFECTION - VERSION 10
海外基金